This list is based on the watchlists of people on Stock Events who follow RFL.BOATS. It's not an investment recommendation.
This list is an analysis based on recent market events. It's not an investment recommendation.
Rafael Holdings, Inc. holds interests in clinical and early stage pharmaceutical companies, and commercial real estate assets in the United States and Israel. The company operates in two segments, Pharmaceuticals and Real Estate. It engages in the leasing of a commercial office building, as well as an associated 800-car public garage; and development and commercialization of therapies that exploit the metabolic differences between normal cells and cancer cells. The company's lead drug candidate is CPI-613 (devimistat), which is being evaluated in various clinical studies, including two Phase III registrational clinical trials for the treatment of metastatic pancreatic cancer and r/r acute myeloid leukemia. Rafael Holdings, Inc. is headquartered in Newark, New Jersey.
Show more...
FAQ
What is Rafael stock price today?▼
The current price of RFL.BOATS is $1.22 USD — it has increased by +0% in the past 24 hours. Watch Rafael stock price performance more closely on the chart.
What is Rafael stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Rafael stocks are traded under the ticker RFL.BOATS.
What is Rafael market cap?▼
Today Rafael has the market capitalization of 62.19M
What is Rafael revenue for the last year?▼
Rafael revenue for the last year amounts to 1.83M USD.
What is Rafael net income for the last year?▼
RFL.BOATS net income for the last year is -61.04M USD.
Does Rafael pay dividends?▼
Yes, RFL.BOATS dividends are paid semi-annual. The last dividend per share was 12.82 USD. As of today, Dividend Yield (FWD)% is 0%.
When did Rafael complete a stock split?▼
Rafael has not had any recent stock splits.